2019
DOI: 10.1073/pnas.1912602117
|View full text |Cite
|
Sign up to set email alerts
|

Mouse genetics reveals Barttin as a genetic modifier of Joubert syndrome

Abstract: Genetic and phenotypic heterogeneity and the lack of sufficiently large patient cohorts pose a significant challenge to understanding genetic associations in rare disease. Here we identify Bsnd (alias Barttin) as a genetic modifier of cystic kidney disease in Joubert syndrome, using a Cep290-deficient mouse model to recapitulate the phenotypic variability observed in patients by mixing genetic backgrounds in a controlled manner and performing genome-wide analysis of these mice. Experimental down-regulation of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2
2

Relationship

4
6

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 36 publications
0
17
1
Order By: Relevance
“…We noted that while 3 dpf MZcep290-/-mutants initially show an axis curvature phenotype similar to the morpholino knockdown phenotype, axis curvature recovered suggesting the axis phenotype was transiently and partially suppressed. To further explore the possibility of phenotype suppression in MZcep290 -/-mutants, we assayed for nonsense-associated altered splicing of mutated exons as has been reported to account for varying expressivity in CEP290 patients (Barny et al, 2018;Littink et al, 2010;Ramsbottom et al, 2020). RT-PCR analysis of mutant and wild type cep290 mRNA exon structure using primers designed for ten exons flanking the mutated exon 16 (Fig 4C ) did not detect changes in amplicon sizes between wild type and mutants, suggesting that exon skipping does not account for differing degrees of cep290 deficiency phenotype severity.…”
Section: Cep290 Mutant Expressivity Is Not Due To Exon Skipping or Nonsense Mediated Decay Mechanismsmentioning
confidence: 99%
“…We noted that while 3 dpf MZcep290-/-mutants initially show an axis curvature phenotype similar to the morpholino knockdown phenotype, axis curvature recovered suggesting the axis phenotype was transiently and partially suppressed. To further explore the possibility of phenotype suppression in MZcep290 -/-mutants, we assayed for nonsense-associated altered splicing of mutated exons as has been reported to account for varying expressivity in CEP290 patients (Barny et al, 2018;Littink et al, 2010;Ramsbottom et al, 2020). RT-PCR analysis of mutant and wild type cep290 mRNA exon structure using primers designed for ten exons flanking the mutated exon 16 (Fig 4C ) did not detect changes in amplicon sizes between wild type and mutants, suggesting that exon skipping does not account for differing degrees of cep290 deficiency phenotype severity.…”
Section: Cep290 Mutant Expressivity Is Not Due To Exon Skipping or Nonsense Mediated Decay Mechanismsmentioning
confidence: 99%
“…It is important to note that the type of genetic defect in animal models (knockout/loss of function or missense mutations) and the genetic background strain with associated genetic modifiers impact the severity of the phenotype and the utility of the model for human disease, as was demonstrated in mouse models of Cep290-associated ciliopathies (Ramsbottom et al, 2015(Ramsbottom et al, , 2020. Patient-derived in vitro systems, for example urinary renal epithelial cells (URECs), kidney tubuloids and organoids, could partly solve these issues (Schutgens et al, 2019;Steichen et al, 2020).…”
Section: Available Model Systems Animal Modelsmentioning
confidence: 99%
“…Indeed, additional signaling pathways are linked to cilia including others known to be important in cell proliferation and axon guidance. Loss of either of the JSRD-linked genes Ahi1 or Cep290 in mouse leads to a small cerebellar vermis due to aberrant Wnt signaling (Lancaster et al 2011; Ramsbottom et al 2020). JSRD-causing mutations in Znf423 are linked to defects in Wnt, BMP and retinoic acid signaling (Hata et al 2000, Huang et al 2009, Casoni et al 2020, Deshpande et al 2020).…”
Section: Introductionmentioning
confidence: 99%